Top Stories
-
Lisa Kachnic, MD, the new chair of radiation oncology at Columbia University Irving Medical Center, has helped pioneer techniques that deliver radiation therapy to cancer patients with more precision.
Topic
-
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.
-
Researchers in Columbia's medical and engineering schools have edited a strain of non-pathogenic bacteria to colonize solid tumors in mice and safely deliver potent immunotherapies.
-
Barring ovarian cancer surgery at low-volume hospitals could limit access to care for many rural and underserved patients, a new study has found.
Topic
Latest News
- December 16, 2016
Researchers have found that blocking nerve growth factor inhibits the formation of stomach cancers, according to a study in mice.
Topic
- December 5, 2016
In a phase 1 study, eight out of 12 patients with relapsed and/or refractory blood cancers responded to a combination of two common chemotherapy drugs.
Topic
- November 21, 2016
Three CUMC scientists have been named AAAS Fellows: Max Gottesman, Wei Gu, and Paul Sajda.
Topic
- November 4, 2016
Dr. Drake studies the body’s immunological response to radiation therapy and how immunotherapy and radiation therapy can be used in concert to treat cancer.
Topic
- September 14, 2016
In mice studies, targeting the SET protein revives p53, a potent tumor suppressor, and prevents cancer growth.
Topic
- July 21, 2016
Adding a new drug called olaratumab to traditional chemotherapy increased survival in sarcoma patients, researchers at Columbia University Medical Center have found.
Topic
- July 15, 2016
The three-dimensional structure could help researchers develop novel therapies and diagnostic tools for diseases that are caused by a malfunction in calcium adsorption.
Topic
- July 12, 2016
According to a new report published in JAMA Oncology, women with BRCA1 mutations have a higher risk of developing an aggressive type of uterine cancer.
Topic
- July 8, 2016
$4 million grant gives Columbia, Weill Cornell Medicine, NewYork-Presbyterian, and NYC Health + Hospitals key role in precision medicine cohort program.
Topic
- July 1, 2016
CUMC, NYP, and Weill Cornell are participating in a care delivery model that supports and encourages higher quality, more coordinated cancer care.
Topic
